Featured Testimonials
THOR on Facebook
THOR on Twitter
THOR on LinkedIn
THOR on Google+
THOR on Instagram
THOR on YouTube
“I love Thor. The product is great. The seminar was very informative and helpful. And the post-purchase support with Mark and the research assistant has been nothing short of exceptional. I feel like I definitely made the right decision by choosing to purchase a Thor Laser. Thanks.”
Dr. Darren Bell
Chiropractor
New York, USA
View current photobiomodulation therapy training dates in your location.
Aaron Nelson, Athletic Care/Head Athletic Trainer of Phoenix Suns explains why their players are using the NovoTHOR. He says the NovoTHOR is a very interesting piece of equipment for performance, recovery and speeding up the healing process throughout the whole body.
View current photobiomodulation therapy training dates in your location.
Disclaimer: These comments by healthcare professionals and their patients are solely their own. They are uncompensated personal stories about how they have used, or been impacted by, light therapy. These uses have not been reviewed or cleared by FDA.
LumiThera® Inc., a commercial-stage medical device company focused on developing photobiomodulation (PBM) therapies for ocular disorders and diseases, announced that it will participate in the combined exhibition of the 18th EURETINA Annual Meeting and the 36th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), held in Vienna, Austria from the 20th to the 26th of September 2018.
EURETINA actively promotes new diagnostic developments, advances in vitreoretinal surgery, the development and application of new drugs, and changes in the treatment of macular degeneration.
LumiThera will debut the Valeda™ Light Delivery System for the treatment of dry AMD in the exhibition hall and will host a symposium on PBM technology entitled, “Photobiomodulation: An Innovative, Mitochondria-targeted Therapy for Dry AMD and Other Ocular Diseases” on September 20th.
Read the full press release:
LumiThera, Inc. to Debut Valeda Light Delivery System at the 18th Congress of the EURETINA
Disclosure: I am an investor in Lumithera a) because it successfully treats an unmet medical need, (dry AMD) b) I think it will be the first billion dollar photobiomodulation company.
36 Photobiomodulation therapy papers published in February 2018. Highlights include:
Ronald E. Hirschberg DVM talks about how using THOR’s equipment has strengthened his relationships with his clients and improved their pet’s health.
Read more about Veterinary Photobiomodulation Therapy
Disclaimer: These comments by healthcare professionals and their patients are solely their own. They are uncompensated personal stories about how they have used, or been impacted by, light therapy. These uses have not been reviewed or cleared by FDA.
Meagan is a National Level Weightlifter who competes frequently. See her story and experience below after sessions on the NovoTHOR whole-body light pod. PR stands for Personal Record.
Wednesday 3/16:
Muscle Snatch Triple off a riser: PR working weight at 42 kg… Up 5 kilos from last week where I could only hit 37kg for working weight.
Thursday 3/17:
My 3/6 front squat/back squat combo I added 3 kilos from the previous Thursday- which is the most working I’ve ever done for this exercise at 91kg.
THEN I went on to do several reps of cleans and hit a 95kg Clean PR (9 kilos more than I did last week- heaviest clean I hit last week was 86kg.) This was halfway through my workout after doing a total of 117 reps. In Weightlifting a lot of volume can make your body feel tired & wrecked, so there was no explanation for why I was able to hit a PR on this exercise when my legs were fried.
Saturday 3/19: I hit a 3 kilo PR on my Power Clean & Jerk at 83kg
Sunday 3/20:
I added 2 kilos to my snatch triples from the blocks (59kg) from last week where I could only do 57kg.
I also did the most working weight I’ve ever done for Clean & Jerk Doubles at 83kg.
Monday 3/21:
Sumo Deadlift triple: 127kg PR (up 5 kilos from last Monday 3/14 I only could hit 122kg for 3)
Snatch Deadlift 5 rep: PR working weight for 5 at 91kg (2 kilos more than last Monday.)
Push Press+Push Jerk + Split Jerk Complex: 75kg (up 2kg from last Monday’s workout)
This part of my training cycle has been very strength intensive, so for me to even be coming close to hitting PRs is a huge deal. My body should be more fatigued and worn down from the strength work, but I actually feel recovered and fresh.
This is all thanks to the NovoTHOR light pod.
The US National Library of Medicine (NLM) plans to adopt “Photobiomodulation Therapy” (PBMT) as an official MeSH term in November 2015.
Why this is important?
This 15 minute video starts with an overview of Photobiomodulation and low level light therapy. Later in the presentation James introduces the Lumithera treatment for Dry Age related Macular Degeneration (AMD).
The paper “High-intensity versus low-level laser therapy in the treatment of patients with knee osteoarthritis: a randomized controlled trial” Kheshie et al 2014 pitches the 3B BTL laser against the HIRO class IV “High intensity” laser. The results appear to show that the HIRO class IV “High intensity laser” was more effective than the “Low Level Laser”. HOWEVER, the HIRO class IV “High intensity” laser was delivered over a large area (not adequately defined but approx 100cm2 by my estimation) so the intensity was actually very low (about 13mW/cm2 which is less than most LED systems), and the 3B BTL “Low Level Laser” was actually very high (4 x 200mW small, high intensity beams) and were held stationary on the patella for over half an hour, YES, HALF AN HOUR IN ONE SPOT! This is insane.
This paper leads people to think that the class IV Hiro laser was more effective because it was higher intensity when in fact the beam distribution meant the average intensity distribution was low (13mW/cm2). The 3B laser was not so effective because it was held stationary such that it would cause an overdose. If the 3B laser treatment had been delivered in using same scanning technique as the class IV then they would likely have achieved the same result. (I am not a fan of scanning because you can never be sure how much energy you have delivered to an area, better to use a low intensity device and hold it still in my view).
This paper misdirects the reader towards favouring class IV lasers rather than 3b or LED by misinforming the reader.
The title of last months PMLS editorial was Low Level Laser Therapy (LLLT) and World Association for Laser Therapy (WALT) Dosage Recommendations. Written by the Scientific Secretary Prof. Jan Bjordal. He describes how far we have come and the importance of the WALT dosage recommendations. No abstract is available for editorials so I have prepared one for you below. Continue reading
A paper titled ”The Effectiveness of Therapeutic Class IV (10 W) Laser Treatment for Epicondylitis” [ref] showed that 10 Watt Class IV laser (mixed 8W 970nm, 2W 810) was successful in reducing pain and improving function in an RCT with 15 patients, and that there was good statistical significance at 6 months following a course of 6 treatments.
The claim by class IV laser manufacturers is that class IV lasers are better (faster, deeper and more effective) than Class 3b and LED systems. Conversely the 3B laser and LED manufacturers argue that less power density is more effective because delivering energy too quickly can overdose tissues and class IV lasers might burn the skin.
Throughout this paper there are marketing messages claiming the advantages of shorter treatment times than low power LLLT systems and of course the title shouts “10 Watt Class IV laser” just in case the reader is in any doubt that more power is what you need.
Regular readers of this column know my obsession with irradiation parameters, particularly dose rate effects (W/cm2) and will not be surprised to learn that I deconstruced the irradiation parameters used in this trial . Surprise, surprise they were the same low irradiance levels typically used by 3B lasers and LED systems, if not less and the treatment time was longer too.
Yes, it was a 10 Watt laser and yes, 3,000 joules was delivered, however it had a large beam area and treatment was delivered over (45cm2) in a “painting fashion”. The fluence (dose) was 6.6 Joules/cm2 and the power density was a tiny 22mW/cm2, consequently treatment time was a hefty 5 mins.
The average irradiance was not disclosed in the paper and the reader is directed to think that more power is quicker.
P.S. research trials with 3B lasers are typically 30 seconds to 3 mins and our recommended treatment is 1 min with a large LED cluster to the lateral epicondyle and 30 seconds for any related trigger points.
Available only to THOR Customers and/or people who have attended a THOR training course in the last 3 years. All treatments are based on our four step method which includes treatment of the injury, trigger points, lymphatics and nerve roots.
Take a look to see how it works and let us know what you think.
Access Treatment Protocol Library
“The course was excellent, stimulating and profound. James Carroll’s presentation was highly inspirational and covered very thoroughly all clinical applications of cold lasers supported by robust clinical evidence. I’m truly motivated that PBM could be broadly used in dentistry; its availability may contribute to faster healing, better pain management and perhaps risk reduction of some common oral diseases. Many thanks for the great day spent with Thor laser.”
Iva Stamatova
Dentist
Hull, UK
View current photobiomodulation therapy training dates in your location.
“Thank you for your excellent course. We bought the THOR laser and use it all week!”
Annie Blain
Dental Hygienist
Montreal, Canada
View current photobiomodulation therapy training dates in your location.
Karen of ATP Therapy shares her experience incorporating the NovoTHOR and the THOR LX2 into their practice and the impact on their patients.
View current photobiomodulation therapy training dates in your location.
Disclaimer: These comments by healthcare professionals and their patients are solely their own. They are uncompensated personal stories about how they have used, or been impacted by, light therapy. These uses have not been reviewed or cleared by FDA.
UK and Ireland dates
USA and Canada dates
Australia and NZ dates
Rest Of World dates